- Home
- MDCXW
MDCXW
Medicus Pharma Ltd. Warrant
as 12-18-2024 2:09pm EST
Stocks
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Medicus Pharma Ltd. Warrant News
MDCXW Breaking Stock News: Dive into MDCXW Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
Medicus Pharma up 9% in Pre-market Trading as FDA Approves Anti-cancer Patch for Horses
GlobeNewswire
6 days ago
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
Clinical Trials Arena
15 days ago
Medicus Pharma and Swanielle partner to expand BCC drug trial to Asia-Pacific
Newsfile
16 days ago
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Zacks Small Cap Research
21 days ago
MDCX: Medicus Pharma 3Q 2024 Financial Results Reported; Stock Now Trades Both in Canada and on Nasdaq After Completing an IPO in the U.S.
Zacks Small Cap Research
23 days ago
V.MDCX: Medicus Pharma Has Begun Trading on Nasdaq under the ticker MDCX after Completing an IPO in the U.S. The SKNJCT-003 Phase 2 clinical trial continues.
Zacks Small Cap Research
23 days ago
V.MDCX: Medicus Pharma Has Begun Trading on Nasdaq under the ticker MDCX after Completing an IPO in the U.S. The SKNJCT-003 Phase 2 clinical trial continues.
Compare MDCXW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDCXW Medicus Pharma Ltd. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.